Psychiatry's greatest limitation is that it has only words as both diagnostic tool and treatment — there is no blood test, no brain scan that says 'this is depression' for an individual patient, making every interview an act of translation from colloquial language to clinically precise symptoms.
2
The #1 barrier to treating mental illness is stigma: patients feel they should be able to handle it alone, and untreated anxiety left for a year or more can convert into depression — adding a second disorder on top of the first.
3
Vagus nerve stimulation was adopted as a brain therapy primarily because the nerve is physically accessible in the neck, not because of deep mechanistic knowledge — a rare honest admission about how psychiatry actually advances.
4
Psychedelics may relieve depression by lowering the brain's filter threshold so that new hypothetical models of the future can escape into consciousness — Deisseroth frames the depressed brain as stuck in a loop that discounts the value of any future action.
Protocols
Concrete recipes — what, when, how much, and why
7 items
Get past jargon in psychiatric interviews by asking about concrete future-directed behaviors
WhatInstead of asking 'are you depressed,' ask about measurable proxies: How much are you planning for the future? How much do you look forward to things? Can you think about what you will do tomorrow? These questions elicit unambiguous, clinically useful answers.
WhenAny intake interview, mental health check-in, or conversation with someone you think may be struggling.
For whomClinicians, coaches, concerned friends or family of someone who may be depressed. Applicable to anyone conducting mental health conversations.
WhyThe word 'depressed' means different things to the physician and the patient. Concrete behavioral questions cut through jargon and surface the hopelessness symptom — the forward-projection failure — which is more diagnostically precise than a label.
Deisseroth describes this as his standard psychiatric interview practice: 'I try to get past the jargon and get to what's actually happening in the patient's life and in their mind.' The key diagnostic insight: if someone says 'I can't even think about tomorrow, I don't see how I'm going to get to tomorrow' — that is a precise, unambiguous signal of the hopelessness symptom. Asking 'how much planning are you doing for the future?' reaches this in a way that asking 'are you depressed?' does not, because the latter can be answered with a socially acceptable 'I'm fine.'
How much do you look forward into the future? How much hope do you have? How much planning are you doing for the future? So these here now you're getting into actual things you can talk about that are unambiguous.
Seek psychiatric treatment before anxiety becomes depression — the one-year conversion risk
WhatIf you have a serious anxiety issue that is interfering with daily life, seek professional help within a year of onset — do not delay due to stigma-driven beliefs that you should be able to handle it alone.
WhenAt the point of recognizing persistent anxiety symptoms, especially if they have been present for months.
DoseCognitive behavioral therapy and medication are both well-established options. CBT alone can be potently effective for panic disorder.
For whomAnyone experiencing persistent anxiety who has been avoiding treatment due to stigma or self-reliance beliefs. Particularly important for high-functioning individuals who can 'manage' on the surface while the condition worsens internally.
WhyUntreated serious anxiety left for a year or more can convert to comorbid depression, adding a second disorder. Treating anxiety early is both cheaper and more effective than treating anxiety-plus-depression later.
Deisseroth names stigma as psychiatry's biggest current challenge: 'patients often don't come to us. They feel that they should be able to handle this on their own, and that can slow treatment.' The conversion pathway from anxiety to depression appears to involve chronic stress-system activation that progressively suppresses motivation and forward-projection circuits — making depression not just an additional diagnosis but a more severe and treatment-resistant state.
We know, for example, patients who have untreated anxiety issues, if you go for a year or more with a serious, untreated anxiety issue, that can convert to depression. You can add another problem on top of the anxiety.
CBT for panic disorder — identifying early cognitions to derail the cascade
WhatCognitive behavioral therapy for panic disorder works by training patients to identify the early cognitive signs that a panic attack is beginning — the specific thoughts and physical sensations that precede the full attack — and to interrupt the cascade at that early stage.
WhenAs a first-line intervention for panic disorder, or alongside medication.
For whomPeople with diagnosed panic disorder. Also applicable to individuals with high anxiety who want to reduce panic-adjacent episodes.
WhyPanic disorder is one of psychiatry's clearest treatment successes with talk therapy alone. The mechanism is cognitive: patients learn to recognize the early warning pattern, which is uniquely identifiable for them, and to deploy counter-cognitions that derail the escalation.
CaveatsThis is a trained skill, not an insight. It requires repetitive practice of the recognition-interruption pattern with a trained therapist before it becomes automatic.
Deisseroth highlights CBT for panic disorder as one of the clearest demonstrations that psychiatry works: 'just working with words, helping people identify the early signs of when they're starting to move toward a panic attack, what are the cognitions that are happening. You can train people to derail that, and you can very potently treat panic disorder that way.' The implication is that the verbal/cognitive tools, precisely because the diagnosis relies on words, are also uniquely capable of intervening at the word-and-model level where the disorder lives.
Cognitive behavioral therapy, just working with words, helping people identify the early signs of when they're starting to move toward a panic attack, what are the cognitions that are happening. You can train people to derail that, and you can very potently treat panic disorder that way.
WhatIn clinical practice, vagus nerve stimulation is titrated in-session: the physician escalates frequency and intensity via a radio-frequency controller while continuously monitoring for side effects (strangulated voice, swallowing difficulty, breathing difficulty). The dose is locked at the highest tolerated level and the patient goes home at that setting.
WhenAt each clinical visit for treatment-resistant depression patients using an implanted vagus nerve stimulator.
DoseDose is set per patient, limited by side effects in the neck (voice, swallowing, breathing). Effects on mood emerge over weeks to months, not immediately.
For whomPatients with treatment-resistant depression who have not responded to medications and/or ECT and have received an implanted vagus nerve stimulator.
WhyBecause the vagus nerve electrode stimulates all electrically responsive tissue in the neck — not just the targeted fibers — dose cannot exceed side-effect tolerance. The titration process is therefore entirely clinical, not protocol-driven.
CaveatsMost patients should not expect immediate mood change at any individual session. Response is evaluated over months. The mechanism is not fully understood.
Deisseroth describes his exact process: 'I use the psychiatric interview to elicit their internal states. And then, I have a radio frequency controller that I can dial in... I can turn up the frequency. I can turn up the intensity... and then the patient can then leave at this altered dose. In most patients, I don't expect an immediate mood change.' The follow-up interval is monthly. This clinical picture illustrates both the genuine potential of neurostimulation and the current gap: we are doing dose-finding by watching faces and listening to voice quality, not by targeting specific therapeutic circuits.
Mechanism
The vagus nerve's solitary tract nucleus is one synapse from serotonin, dopamine, and norepinephrine systems. Stimulation likely modulates these pathways, though the exact mechanism remains uncertain. The dose-limiting factor is non-selective electrical stimulation of all neck structures.
I have a radio frequency controller that I can dial in. I can turn up the frequency. I can turn up the intensity all with the radio frequency and control, and then it's reprogrammed or reduced, and then the patient can then leave at this altered dose.
Deisseroth's personal protocol for deep thinking — deliberate stillness
WhatCarve out dedicated time each day to sit, nearly motionless, with minimal distraction and think — not meditate in the traditional sense, but engage in active structured thought without movement.
WhenDaily, in whatever blocks the schedule allows. Deisseroth does this as a necessary condition for abstract, complex thinking.
For whomAnyone whose work requires sustained abstract thinking. Particularly relevant for those who have tried to think productively while walking or exercising but find their best ideas come in stillness.
WhyDeisseroth noticed that he cannot think complex, abstract thoughts unless his body is almost completely still. For him, the motionless state is not incidental — it is the prerequisite for high-quality cognitive work.
CaveatsDeisseroth acknowledges this is highly individual — some people do their best thinking while running. This is a personal practice, not a universal prescription.
Deisseroth describes this practice explicitly: 'I try to have time in each day where I am literally sitting almost in this position but without distraction and thinking. And so it's almost meditative in some ways, except it's not a true meditation. But I am thinking, well, not moving.' He notes this is how he approaches the demands of running a large research lab, doing clinical psychiatry, and writing books simultaneously — structured, motionless contemplation time is a non-negotiable input. The contrast with Huberman's use of zone-2 cardio for thinking highlights that the optimal state for deep cognition is genuinely individual.
Personal experience
Deisseroth: 'I notice I have to think complex, abstract thoughts. I notice I have to be very still. So my body has to be almost completely unmoving for me to think very abstractly and deeply. Other people are different. Some people, when they're running, they get their best thoughts. I can't even imagine that. My brain does not work that way at all.'
I try to have time in each day where I am literally sitting almost in this position but without distraction and thinking. And so it's almost meditative in some ways, except it's not a true meditation. But I am thinking, well, not moving.
ECT as the most effective intervention for treatment-resistant depression
WhatElectroconvulsive therapy (ECT), administered under full anesthesia with complete muscle relaxation so the body does not seize, triggers an internal brain process that is extraordinarily effective for treatment-resistant depression.
WhenFor patients who have failed multiple medication trials or cannot tolerate medications.
For whomPatients with severe, treatment-resistant depression. Particularly relevant when medication tolerance is the limiting factor.
WhyECT remains one of psychiatry's highest-efficacy tools. The modern form — body paralyzed by anesthesia, only an internal brain process occurs — is safe and tightly controlled. Deisseroth acknowledges it is frustratingly imprecise but genuinely effective.
CaveatsDeisseroth is explicit about his frustration: 'Why can't we do something more precise than this for these very severe cases.' ECT is effective but mechanistically opaque — the broad-brush neural reset works without full understanding of why.
Deisseroth describes ECT as both 'heartening' and 'frustrating' — heartening because patients with severe depression who have failed everything else do respond, frustrating because it represents the gap between what psychiatry can do and what it understands. The comparison to cardiology is telling: cardiology knows its system is a pump, which gives it an explanatory framework for every intervention. Psychiatry does not yet have the equivalent framework for what the relevant circuits are 'for.' ECT is the clearest example of a treatment that works without that framework.
This is an extraordinarily effective treatment for treatment resistant depression. At the same time, I find it as heartening as it is to see patients respond to this with who have severe depression. I'm also frustrated by it. Why can't we do something more precise than this for these very severe cases.
Diagnose ADHD across domains — school AND home, not just one setting
WhatADHD diagnosis requires demonstrating that the attentional symptoms are pervasive across multiple domains of life — school, home, work — and not specific to one teacher, one parent, or one context. Symptoms present in only one setting suggest the trigger is situational, not a core disorder.
WhenAt the point of evaluating whether someone meets criteria for ADHD.
For whomParents and clinicians evaluating children and adolescents. Also relevant for adults seeking self-assessment.
WhyADHD is a pervasive pattern, not a context-specific one. Confirming cross-domain presence distinguishes true ADHD from situational mismatch (e.g., a child whose attention fails only with a particular teaching style).
CaveatsADHD can present with hyperactivity predominant, inattention predominant, or combined — these are distinct presentations that can exist independently. Stimulant treatment is effective but the appropriate treatment fraction is an area of active debate.
Deisseroth notes ADHD is also an area where quantitative EEG-based diagnosis is under active development: specific brainwave rhythms detectable with an external skullcap may eventually allow clinic-based objective diagnosis — analogous to the EEG in epilepsy. He describes the current diagnostic standard as requiring presence across school and home 'to show that it really is a pervasive pattern and not something specific to the teacher or the home situation or something.' He also distinguishes ADHD from the phone-use tic pattern, noting the latter does not disrupt social or occupational functioning by current standards.
The key thing is we want to make sure that this is present across different domains of life, school and home, to show that it really is a pervasive pattern and not something specific to the teacher or the home situation or something.
What's new
Personal practice updates, fresh positions, predictions
6 items
The cortex is a hypothesis-generation and testing machine — psychedelics lower the filter
~42 min
Deisseroth describes the cortex as constantly generating models and hypotheses about the world from incoming data — most of which are filtered out before reaching consciousness. Psychedelics change the threshold for which hypotheses escape into awareness, letting in incomplete or 'wrong' models that the brain normally suppresses.
Why this matters: This framing reframes psychedelic states not as chaos but as relaxed Bayesian filtering — and directly explains both why psychedelics can be therapeutic (new models of possibility emerge) and why they can be harmful (schizophrenia-like delusions are also models that shouldn't have escaped).
Background
Standard psychopharmacology frames LSD and psilocybin primarily as serotonin 2A receptor agonists causing widespread neural connectivity. Deisseroth's framing is circuit-level and computational rather than receptor-level.
Deisseroth uses this framing explicitly to explain schizophrenic paranoia: 'the paranoid delusions that people have are examples of these poor models that escape into the conscious mind and become accepted as reality, and they never should have gotten out there.' The therapeutic implication for depression is inverse: depression is a state where the brain is stuck — it won't let new models of a positive future escape into consciousness. Psychedelics may selectively unblock that filter. This is not yet proven rigorously but Deisseroth says the lab is studying it directly by recording cells that 'represent steps along a path and look into the future' during psychedelic states.
What the psychedelics seem to do is they change the threshold for us to become aware of these incomplete hypotheses or wrong hypotheses or concepts that might be noise but are just wrong. And so are never allowed to get into our conscious mind.
Also said
“The brain and in particular, our cortex, I think, is a hypothesis generation and testing machine. It's coming up with models about everything.”— Establishes the computational baseline — why the filtering process exists in the first place.
“In schizophrenia, some of the times, the paranoid delusions that people have are examples of these poor models that escape into the conscious mind and become accepted as reality, and they never should have gotten out there.”— Shows the same mechanism going wrong — excess filter-lowering, not just beneficial filter-lowering.
Depression as a 'stuck forward-projection' — the brain stops modeling a viable future
~44 min
Deisseroth describes depressed patients not just as sad but as unable to forward-project. They discount the value of their own actions and of the world's capacity to produce a future that matters. He uses the metaphor of a river running out into the desert and drying up — forward movement stops.
Why this matters: This is a precise computational description of hopelessness, grounded in neuroscience. It also directly explains why CBT and behavioral activation work: they force incremental forward modeling even when the patient discounts the output.
Deisseroth explains that he tries to make the psychiatric interview concrete precisely because of this dynamic. He asks not 'are you depressed' but 'how much do you look forward to the future? How much planning are you doing?' A patient who says 'I can't even think about tomorrow, I don't see how I'm going to get to tomorrow' is expressing the hopelessness symptom precisely and unambiguously. That symptom is a measurable proxy for the forward-projection deficit even without a brain scan.
Everything seems hopeless, and what does that really mean? They discount the value of their own action. They discount the value of the world at giving rise to a future that matters. Everything seems to run out like a river, just running out into the desert and drying up.
Also said
“What these agents may do that increase the flow through circuitry, if you will, the percolation of activity through circuitry may end up doing for depression is increasing the escape of some tendrils of process of forward progression through the world.”— The specific hypothesized mechanism by which psychedelics might reverse depressive forward-projection failure.
Vagus nerve stimulation adopted because of accessibility — not mechanistic knowledge
~28 min
Deisseroth makes an unusually candid admission: the vagus nerve was targeted for depression therapy primarily because it is physically accessible in the neck, not because of confident understanding of the mechanism. It did have a plausible rationale (the solitary tract nucleus is one synapse from serotonin/dopamine systems), but he says even without that link, it would have been tried.
Why this matters: Rare honest acknowledgment that much of psychiatric device therapy is opportunistic engineering — 'it's accessible, so we tried it' — rather than mechanism-first science. This is a useful calibration for anyone evaluating claims about neurostimulation devices.
Background
Vagus nerve stimulation was originally developed for epilepsy, then tried for depression. The FDA has approved it for treatment-resistant depression.
The side-effect profile of current vagus nerve stimulation illustrates the accessibility-driven limitation directly: because the electrode stimulates everything electrically responsive in the neck, patients get strangulated voice, trouble swallowing, trouble breathing. Dose is capped by these side effects, not by therapeutic threshold. Deisseroth describes his clinical practice: in real time, he uses a radio-frequency controller to titrate the stimulator while watching the patient's face and asking 'can you still breathe? Can you still swallow?' — stopping at whatever looks safe, then sending the patient home at that dose for a month. Results are evaluated at the next visit.
I can tell you that even if that were not true, the same thing would have been tried. Because it's accessible.
Also said
“The vagus nerve lands on a particular spot on the brain called the solitary tract nucleus, which is just one synapse away from the serotonin and dopamine and norepinephrine.”— The post-hoc rationale that makes vagus nerve stimulation not irrational — even if accessibility was the real driver.
“When you turn on the vagus nerve stimulator, the voice patient's voice becomes strangulated and hoarse. They can have trouble swallowing. They can have trouble speaking, for sure, even some trouble breathing because everything in the neck, every electrically responsive cell and projection in the neck is being affected by this electrode.”— The concrete side-effect profile that reveals the lack of precision — the price of accessibility.
MDMA works by teaching the brain what social connection feels like — the state itself is the lesson
~50 min
Deisseroth's explanation for why MDMA-assisted therapy works for PTSD is not pharmacological but learning-theoretic: the brain learns from the acute state of extreme connectedness with other people. Even after the drug wears off, patients retain the knowledge that 'this level of connection is possible — there don't need to be as many barriers as I thought.'
Why this matters: Reframes MDMA therapy from 'chemical rescue' to 'experiential learning' — which is also why the experience itself matters and why non-hallucinatory chemical variants may miss the point.
Deisseroth explicitly draws the parallel to good psychoanalysis: in both cases, the relationship (or drug state) provides a test environment where new relational models can be tried and learned. 'All good psychiatrists try to achieve that level of connection and learning, try to help patients create a new model that is stable, that is learned and that can help instruct future behavior.' The MDMA state is a pharmacologically induced version of the corrective emotional experience that therapy aims for.
I think the brain learns from those experiences. And so what people will report is, yeah, I'm not in that state. But I saw what was possible. I saw, yeah, you can — it doesn't need to be barriers or at least not as many barriers as I thought.
Also said
“I think it's the learning that happens in that state that actually matters.”— The one-sentence thesis: the pharmacology is the vehicle, the learning is the mechanism.
Phone-checking has tic-like neurological structure — but doesn't meet clinical threshold
~38 min
Deisseroth validates Huberman's observation that compulsive phone-checking resembles OCD-like tic behavior: there is a buildup of urge, a relief upon execution, and a small reward. But psychiatric diagnosis requires social or occupational disruption — and checking a phone currently helps social and occupational functioning, so it cannot be diagnosed.
Why this matters: Crystallizes why 'tech addiction' is a conceptual grey zone in psychiatry: the mechanism is similar to OCD tics, but the diagnostic threshold is functional disruption, not symptom presence. This may change as the functional costs of phone use shift.
Huberman disclosed a childhood grunting tic that disappeared by age 16-17, and described how impact sports (skateboarding, boxing) brought relief — suggesting his own tic had a sensory-regulatory component. Deisseroth notes tics can be motor movements, vocalizations, or even thoughts, and that the commonality is a buildup of something that can only be relieved by executing the tic. The phone parallel is structurally identical. The key diagnostic distinction: 'we don't diagnose something unless it's disrupting what we call social or occupational functioning.'
If they haven't checked their phone in a while, they do have a buildup and build up and build up until they can check it and relieve it. And there's some similarities. There is a little reward that comes with the checking.
Also said
“Every psychiatric diagnosis requires that it has to be disrupting someone's social or occupational functioning. And these days, checking your phone is pretty adaptive. That pretty much helps your social and occupational functioning. And so we can't make it a psychiatric diagnosis.”— The formal line Deisseroth draws — tic-like mechanism without clinical pathology because the behavior is currently functional.
Untreated anxiety can convert to depression within a year
~10 min
Deisseroth highlights that stigma — patients believing they should handle psychiatric issues alone — creates a measurable clinical harm: untreated anxiety left for a year or more can convert to depression, adding a second disorder on top of the first.
Why this matters: Puts a concrete timeline on the cost of treatment avoidance due to stigma. It is not just delayed relief — it is risk of acquiring an additional disorder.
Deisseroth frames stigma as psychiatry's largest systemic challenge today. Patients with anxiety disorders have a plausible path to self-management, which makes the stigma-driven avoidance feel rational even as it damages them. The conversion from anxiety to depression appears to involve the dysregulation of stress systems that, when chronically activated, begin to suppress motivation and forward-projection circuits.
Patients who have untreated anxiety issues, if you go for a year or more with a serious, untreated anxiety issue, that can convert to depression. You can add another problem on top of the anxiety.
Recommendations
Products, supplements, and tools mentioned in the episode
3 items
Cognitive Behavioral Therapy (CBT) for panic disorder and anxiety
Tool
Deisseroth cites CBT for panic disorder as one of psychiatry's clearest success stories — just working with words, it can 'very potently treat panic disorder.' He frames it as evidence that verbal/cognitive tools can be highly effective precisely because psychiatric disorders live at the word-and-model level.
Deisseroth's broader point is that psychiatry's limitations (words as the only tool) are also the source of some of its greatest strengths. Because panic disorder is essentially a cascade of maladaptive cognitions and predictions, intervening with cognitions — what CBT does — attacks the root. 'You can train people to derail that.' The treatment does not require a biological mechanism to be understood; it works through the same medium as the disorder.
Cognitive behavioral therapy, just working with words, helping people identify the early signs of when they're starting to move toward a panic attack, what are the cognitions that are happening. You can train people to derail that, and you can very potently treat panic disorder that way.
Vagus nerve stimulation (implanted) for treatment-resistant depression
Tool
FDA-cleared for treatment-resistant depression. Deisseroth uses it clinically and describes the real-time titration process. Appropriate for patients who have exhausted medication options.
Deisseroth describes the clinical reality candidly: the mechanism is uncertain, the dose is limited by neck side effects, and efficacy unfolds over months. But for patients who have failed everything else, it is a legitimate option. The optogenetics research his lab is pursuing aims to eventually deliver a precise version of the same therapy — targeting specific fiber types rather than all electrically responsive tissue in the neck.
vs alternatives
ECT is more potent and faster-acting for severe cases but requires anesthesia and hospital visits. VNS is a set-and-monitor outpatient approach. Antidepressant medications are first-line but may be ineffective or intolerable. Optogenetics (not yet human-ready) is the theoretical precision successor.
I do vagus nerve stimulation. I talk to them. I say how I go through the symptoms. I use the psychiatric interview to elicit their internal states. And then, I have a radio frequency controller that I can dial in.
Deisseroth notes that even a single stimulation electrode in the brain — not a complex closed-loop system — can help people with OCD quite powerfully. This is an existing clinical tool, not a future research direction.
Deisseroth frames DBS as evidence that brain-machine interface technologies are already contributing to psychiatric treatment, not just neurological treatment. The key point is that even a blunt, single-electrode intervention without closed-loop feedback can be effective. Closed-loop systems that both stimulate and record — the next generation — would be more targeted and adaptable. He situates DBS within a broader trajectory: brain-machine interface will be part of psychiatry long-term.
Even just a single stimulation electrode in the brain can help people with OCD, for example, quite powerfully.
Projections: A Story of Human Emotions by Karl Deisseroth
Book Sponsored · disclosed
Deisseroth's book combines clinical case studies from his psychiatric practice with the neuroscience of channelrhodopsins and optogenetics. The dual goal was to remain rigorously close to the science while remaining accessible to a general reader.
DisclosureGuest's own book, discussed and promoted throughout the episode.
Deisseroth describes the writing challenge: 'I wanted to stay absolutely rigorously close to the science, what was actually known... and yet letting people see the hope that everybody see that we've come a long way; we have a long way to go. But the trajectory and the path is beautiful.' Huberman describes it as 'a masterful book, really, and one that as a scientist and somebody who is a fellow brain explorer, hits all the marks of rigor and is incredibly interesting, and there's a ton of storytelling.' The book's thesis is that human emotional states — depression, mania, fear, grief — can be understood through the lens of specific neural circuits, and that understanding gives grounds for both precision medicine and genuine optimism.
I wanted it to be for everybody, literally everybody in the world who wants to read it. And yet, at the same time, I wanted to stay absolutely rigorously close to the science, what was actually known.
Lines worth pulling out — contrarian, specific, or perfectly phrased
5 items
We've got the most complex, beautiful, mysterious, incredibly engineered object in the universe. And yet, all we have are words to find our way in.
Deisseroth's framing of the core paradox of psychiatry — the mismatch between the complexity of the subject and the crudeness of its primary tool.
I can tell you that even if that were not true, the same thing would have been tried. Because it's accessible.
Unusually candid admission that psychiatric device therapy is often opportunistic engineering rather than mechanism-first science — a calibration point for anyone evaluating neurostimulation claims.
Everything seems to run out like a river, just running out into the desert and drying up.
Deisseroth's precise, evocative description of the phenomenology of depression as forward-projection failure — useful for clinicians trying to communicate the disorder to patients and families.
I think the brain learns from those experiences. And so what people will report is, yeah, I'm not in that state. But I saw what was possible.
The learning-theoretic framing of MDMA-assisted therapy — the experience teaches the brain a new relational model, not just a temporary chemical state.
Patients who have untreated anxiety issues, if you go for a year or more with a serious, untreated anxiety issue, that can convert to depression. You can add another problem on top of the anxiety.
Concrete clinical consequence of stigma-driven treatment avoidance — not just delayed relief but acquisition of a comorbid disorder.
Sign in to share feedback
Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.
Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.
Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.
